GS-5734 to Assess the Antiviral Activity, Longer-Term Clearance of Ebola Virus, and Safety in Male Ebola Survivors With Evidence of Ebola Virus Persistence in Semen
Clinical trial NCT02818582 · COMPLETED
Trial details
- NCT number
- NCT02818582
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-07-01
- Primary completion
- 2020-08-31
- Enrollment
- 38
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.